Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

The Destiny 2 Renegades patch notes for version 9.5.0 are here, and they take aim at the Portal, weapon changes, and much ...

Destiny 2's Renegades update is live this December 2 as console version 1.177/3.82. This ushers in the new Star Wars content ...

Khadija Khartit is a strategy, investment, and funding expert, and an educator of fintech and strategic finance in top universities. She has been an investor, entrepreneur, and advisor for more than ...

Destiny 2 releases its highly anticipated Renegades expansion alongside a massive update that adds significant, player-friendly changes.

The HackerEarth platform itself is pretty standard for online coding tests. You’ll have a code editor where you write your ...

Your LeetCode profile is more than just a list of solved problems. It’s a story about your coding journey, your ...